Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

151.28 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,289
Open 151.28
Bid (Size) 150.93 (1)
Ask (Size) 151.50 (1)
Prev. Close 151.28
Today's Range 151.28 - 151.28
52wk Range 144.95 - 181.04
Shares Outstanding 2,628,679,824
Dividend Yield 3.15%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2 Unstoppable Dividend Stocks Trading Near 52-Week Lows to Buy Now
With clear advantages over the competition, these divided payers could deliver market-beating gains to patient investors. 
Via The Motley Fool
Google Alum's Biotech Startup Cradle Raises $24M To Boost AI-Powered Protein Design And Engineering
Dutch biotech startup Cradle has raised $24 million in Series A funding as it looks to boost its protein design and engineering process. 
Via Benzinga

Performance

YTD
-15.10%
-15.10%
1 Month
+2.89%
+2.89%
3 Month
-7.92%
-7.92%
6 Month
-2.00%
-2.00%
1 Year
-14.69%
-14.69%

More News

Read More
3 Robotics Stocks That Could Be Multibaggers in the Making
Via InvestorPlace
The Shocking Stock That Warren Buffet Just Bought (and 2 He Sold)
Via InvestorPlace
This Is What Whales Are Betting On Johnson & Johnson
Via Benzinga
Is NYSE:JNJ suited for dividend investing?
Via Chartmill
Market Whales and Their Recent Bets on JNJ Options
Via Benzinga
Dividend Aristocrats In Focus: Kenvue
Via Talk Markets
5 Stocks You Can Confidently Invest $500 In Right Now
Via The Motley Fool
Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio
Via The Motley Fool
Johnson & Johnson and Intuitive Surgical Might Become Ozempic's Next Victims. Are They Still Worth Buying?
Via The Motley Fool
Warren Buffett-Led Berkshire Hathaway Sells Its Entire Procter & Gamble Stake. Should You?
Via The Motley Fool
Heart Failure Drugs Market Critical Analysis with Expert Opinion : Johnson & Johnson, Pfizer, Roche
Via SBWire
How Is The Market Feeling About Johnson & Johnson?
Via Benzinga
Behind the Scenes of Johnson & Johnson's Latest Options Trends
Via Benzinga
21 Analysts Have This to Say About Johnson & Johnson
Via Benzinga
3 Dividend Stocks You Can Safely Hold for Decades
Via The Motley Fool
Skin Tightening Products Market to Witness Massive Growth by 2029 : L'Oréal, Johnson & Johnson, Amway
Via SBWire
Worried About Market Volatility? Invest In These High-Yield Dividend Stocks For Consistent Passive Income
Via Benzinga
3 Biotech Stocks That Could Be Millionaire Makers
Via The Motley Fool
5 Longtime Holdings Warren Buffett Completely Sold During the Third Quarter
Via The Motley Fool
Why Is Depression Focused MIRA Pharmaceuticals Stock Trading Higher Today?
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Stock Market This Week – Sunday, Nov. 19
Via Talk Markets
Topics Economy
Exposures Economy Interest Rates
7 High-Yield Blue Chips Suitable for Any Retiree
Via InvestorPlace
Topics Retirement
Exposures Pension
Johnson & Johnson Resolves 2 Major Talc Cases As Legal Battles Continue
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.